When not to take Mounjaro: the situations that change the decision

The situations where Mounjaro is ruled out completely

Some conditions are hard stops. The Mounjaro prescribing information lists medullary thyroid carcinoma (MTC) and Multiple Endocrine Neoplasia syndrome type 2 (MEN2) as absolute contraindications — if you have a personal or family history of either, tirzepatide is not suitable. The reason relates to thyroid C-cell findings in animal studies; the clinical significance in humans is still being monitored, but regulators have been firm on this point since the medicine was first licensed.

A serious hypersensitivity reaction to tirzepatide or any of the pen's excipients is another outright contraindication. If you have previously reacted to the medicine or a closely related agent, the prescriber will not issue a prescription.

Age is also clear-cut. Mounjaro is licensed for adults only. Anyone under 18 falls outside the approved indication, regardless of BMI or clinical need, and no responsible prescriber will step outside that boundary.

Pregnancy, breastfeeding and actively trying to conceive are all situations where Mounjaro is not recommended. Animal data raised developmental concerns, and there is no adequate human safety data for these groups. If you become pregnant while using the medicine, you should stop it and speak to your GP or midwife promptly. For contraception specifics, the Mounjaro overview page covers the guidance on oral contraceptive absorption in more detail.

Conditions that need careful prescriber assessment, not automatic exclusion

A number of health conditions sit in a more nuanced space: they do not automatically rule Mounjaro out, but they require a prescriber to weigh the risks carefully before deciding. Pancreatitis sits at the top of that list. If you have had acute or chronic pancreatitis in the past, the prescriber must consider whether the medicine's known association with this condition makes it appropriate for you. In January 2026 the MHRA issued a Drug Safety Update on GLP-1 receptor agonists (which covers Mounjaro's dual GIP/GLP-1 mechanism) specifically highlighting the importance of reporting severe persistent abdominal pain that radiates to the back as a potential sign of pancreatitis requiring urgent medical assessment.

Severe gastrointestinal disease, including gastroparesis, is another area requiring careful discussion. Mounjaro slows gastric emptying as part of its mechanism, in someone with pre-existing gastric motility problems, that effect can be poorly tolerated or clinically problematic.

Diabetic retinopathy is flagged in the prescribing information because rapid glucose lowering can occasionally worsen it. People with pre-existing retinopathy should tell their prescriber; it does not necessarily rule out treatment but does require monitoring.

Kidney function also matters. Mounjaro is not recommended in severe renal impairment due to limited data in that population, and the prescriber will review your kidney health as part of the assessment. If you are taking medicines that depend on kidney clearance or that affect hydration, this adds another layer to the risk discussion. You can read about the broader suitability picture on the tirzepatide overview page.

When to stop or pause Mounjaro once treatment has started

Starting treatment does not mean you are cleared forever. There are situations where the right call is to stop or temporarily pause the medicine, and knowing them in advance matters. Planned surgery is one: you should tell the anaesthetist and surgical team that you are using Mounjaro before any procedure, because slowed gastric emptying raises aspiration risk under general anaesthesia. NHS guidance recommends discussing a pause in treatment with your prescribing team ahead of time. Our page on when to stop Mounjaro goes into this in detail.

Severe, persistent nausea or vomiting that is causing significant dehydration is another situation that may warrant a temporary pause rather than pushing through. The same applies to a serious intercurrent illness affecting your kidneys or liver, your prescriber needs to know.

If you are switching doses or considering stopping altogether because treatment isn't working as expected, that decision should involve your prescribing team rather than a unilateral call. Our guidance on when to take your Mounjaro shot covers related practical timing questions, but the stopping decision is a clinical one.

One practical point worth knowing: if you order Mounjaro through a service like ours and something changes in your health before your next supply, contact the clinical team before your next injection day rather than carrying on regardless. Our prescribers are available seven days a week for exactly that kind of conversation. If you're weighing up the cost side of a private prescription, the Mounjaro pricing page explains what a legitimate private prescription includes.

How a responsible prescriber makes this call

The list of contraindications and cautions above is not small, but it does not exist to exclude people unnecessarily. It exists because Mounjaro is a clinically active medicine with real effects on multiple body systems, the prescriber's job is to assess whether those effects work for or against your individual health picture.

At nume, a GPhC-registered Independent Prescriber reads your consultation answers personally on the same day you submit them. That includes reviewing your medical history, current medicines, and the specific questions that these contraindications require asking. Photo ID and live weight verification are part of the process. If something in your history requires clarification, the prescriber follows up rather than guessing.

If you want to understand how the clinical team approaches these assessments, our clinical team page sets out who is reviewing prescriptions and how. For a fuller picture of what the consultation involves, the FAQs cover common questions, and you can always reach the team directly via the contact page.

If you are ready to find out whether Mounjaro is clinically appropriate for you, start your free consultation and a prescriber will review your case the same day.